Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2018 08:00 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit

BERKELEY, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today presented preliminary observations from a case study of a patient with metastatic colorectal cancer...
April 17, 2018 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting

BERKELEY, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that data from three of the company’s programs were presented at the American Association for...
April 02, 2018 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at the H.C. Wainwright Annual Global Life Sciences Conference

BERKELEY, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present...
March 14, 2018 16:31 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting

BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), today announced three preclinical data presentations highlighting its STING and antibody product candidates...
March 14, 2018 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference

BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present...
March 07, 2018 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference

BERKELEY, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Andrea van Elsas, chief scientific officer of Aduro, will present at the 38th Annual Cowen...
March 05, 2018 16:05 ET | Source: Aduro Biotech, Inc.

Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors

BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that the company earned a $3.0 million development milestone payment under its worldwide...
March 05, 2018 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe

BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Hans van Eenennaam, Ph.D. has been promoted to executive vice president antibody research...
March 01, 2018 16:01 ET | Source: Aduro Biotech, Inc.

Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results

BERKELEY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the year ended December 31, 2017. Net loss for the fourth quarter and year...
February 08, 2018 16:31 ET | Source: Aduro Biotech, Inc.

Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference

BERKELEY, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present...